R. Chris Rathbun, Pharm.D., BCPS, AQ-ID

Prof & Chair

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47254

Fax (405) 271-6430

Office CPB 211

Email chris-rathbun@ouhsc.edu


Summary

Research interests are centered in the area of HIV infection and include optimization of antiretroviral therapy, evaluation of novel antiretroviral agents and treatment strategies, medication adherence with antiretroviral regimens, and pharmacokinetic/pharmacodynamics drug interactions among antiretrovirals.



Research

Infectious diseases.




Publications & Presentations

<< 1 2 3 4 5 6 > >>
    11. Miller M M, Liedtke M D, Lockhart S M, Rathbun C. The role of dolutegravir in the management of HIV infection. Infection and Drug Resistance/Dove Press. 2015; 8

    12. Ripley T L, Adamson P B, Hennebry T A, Van Tuyl J S, Harrison D, Rathbun C. Collaborative Practice Model Between Cardiologists and Clinical Pharmacists for Management of Patients With Cardiovascular Disease in an Outpatient Clinic. The Annals of pharmacotherapy. 2014; 48 : 412-419

    13. Kleyn T J, Liedtke M D, Harrison D, Lockhart S M, Salvaggio M R, Ripley T L, Rathbun C. Incidence of Transmitted Antiretroviral Drug Resistance in Treatment-Naïve HIV-1 Infected Persons in a Large South Central United States Clinic. Annals of Pharmacotherapy. 2014; 48 : 470-475

    14. Liedtke M D, Tomlin C R, Miller M M, Lockhart S M, Rathbun C. Long-term efficacy of raltegravir in the management of HIV infection. Infection and Drug Resistance/Dove Press. 2014; 7 : 73-84

    15. Rathbun C, Lockhart S M, Miller M M, Liedtke M D. Dolutegravir, a Second-Generation Integrase Inhibitor for the Treatment of HIV-1 Infection. The Annals of pharmacotherapy. 2013; 48 : 395-403

<< 1 2 3 4 5 6 > >>



Grants

<< 1 2 3 4 5 >>
    11. Clinical Pharmacy Services. HHS. Start Date: 2017. End Date: 2017.

    12. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    13. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    14. HIV Adherence Services. State Agency. Start Date: 2016. End Date: 2017.

    15. Clinical Pharmacy Services. HHS. Start Date: 2016. End Date: 2016.

<< 1 2 3 4 5 >>



Awards and Honors


no results

Education

                                                                                            1.  Degree: BS. University of Minnesota, Duluth. Date: 2005.  

                                                                                            2.  Degree: Infectious Diseases Fellowship. University of Texas at Austin. Date: 1991.  

                                                                                            3.  Degree: PharmD. University of Minnesota, Mpls-St. Paul. Date: 1989.